Atlas Trials

Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II)

Clinical trial NCT04035642 · RECRUITING

Trial details

NCT number
NCT04035642
Sponsor
Fundacao Champalimaud
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2019-06-01
Primary completion
2026-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.